Reverse DCF

What growth rate is priced into Sekisui Chemical Co Ltd ADR (SKSUY)?

At the current market price of $80.57, a reverse DCF implies Sekisui Chemical Co Ltd ADR (SKSUY) must grow revenue about -10.2% per year for the next decade (-16.4% in year one) to be worth what it trades for — holding margins, taxes, reinvestment, and the discount rate fixed at the model's baseline assumptions.

Market price

$80.57

Implied growth (yr 1)

-16.4%

Implied 10-yr CAGR

-10.2%

Run the live reverse DCF with your own assumptions →

Sekisui Chemical Co Ltd ADR (SKSUY) reverse DCF FAQ

What revenue growth rate is priced into Sekisui Chemical Co Ltd ADR (SKSUY)?

At the current market price of $80.57, a reverse DCF implies Sekisui Chemical Co Ltd ADR's revenue must grow about -10.2% per year for the next ten years (starting at -16.4% in year one) to justify the price — holding margins, taxes, reinvestment, and the discount rate at the model's baseline assumptions.

What is a reverse DCF?

A regular DCF turns growth assumptions into a fair value. A reverse DCF inverts that: it holds every other assumption fixed and solves for the single revenue-growth path that makes intrinsic value equal the current market price. The result is the growth the market is already paying for — a hurdle you can judge the business against.

How does the implied growth compare with the model's own SKSUY forecast?

The forward DCF for Sekisui Chemical Co Ltd ADR estimates a fair value of $283.37 per share, implying SKSUY is undervalued at the $80.57 market price. If the market-implied growth is well above what the forward model assumes, the price embeds more optimism than the fundamentals-anchored forecast — and vice versa.

How this SKSUY implied growth is solved

The engine takes the same 10-year DCF used for the Sekisui Chemical Co Ltd ADR fair-value estimate — margins converging to Damodaran industry benchmarks, year-by-year WACC, a reinvestment rate tied to sales-to-capital efficiency — and inverts it: instead of projecting growth to get a value, it bisects on the starting revenue-growth rate, re-running the valuation until intrinsic value matches the market price. The implied path follows the same moat-scored convergence toward the 2% terminal growth rate that the forward model uses.

The interactive version lets you change what is held fixed — margins, convergence timing, industry benchmarks — and overlays the market-implied growth path on your own editable forecast, so you can see exactly where your expectations and the market's diverge.

The implied growth re-solves when Sekisui Chemical Co Ltd ADR files a new quarterly or annual report. For educational/informational purposes only — not investment advice. Last solved 2026-07-16.